Biotech

All Articles

James Wilson leaving behind Penn to launch two new biotechs

.After much more than thirty years, gene therapy innovator James Wilson M.D., Ph.D., is leaving the ...

3 biotechs attempt to trump the summertime heat energy by dropping personnel

.As biotechs seek to turn a fresh webpage in August, at least 3 firms have actually shed personnel i...

venBio lifts $528M for fifth lifestyle sciences VC fund

.Veteran financial backing company venBio has raised yet another half a billion dollars to acquire b...

Otsuka spends $800M for Jnana and also its own clinical-stage PKU medicine

.Otsuka Pharmaceutical has grabbed Boston-based Jnana Therapies for $800 million so the Japanese bio...

FibroGen lays off 75% people workers as resource flunks 2 additional tests

.FibroGen is actually substantially restructuring its company, laying off 75% of its own USA staff a...

Tracon winds down weeks after injectable PD-L1 inhibitor neglect

.Tracon Pharmaceuticals has chosen to relax procedures weeks after an injectable invulnerable checkp...

Ideaya bags alternative on Biocytogen bispecific ADC in $400M offer

.Ideaya Biosciences is betting $400 million in biobucks that a bispecific antibody-drug conjugate (A...

Takeda takes $140M reduction on fallen short epilepsy drug, promotes FDA manage

.Our company presently recognize that Takeda is intending to find a path to the FDA for epilepsy med...

VBI Vaccines apply for bankruptcy, seeks asset purchase

.Immunology biotech VBI Injections is turning dangerously close to the climax, with plans to apply f...

Celldex anti-cKIT antitoxin reduce colonies in an additional period 2 research study

.It's challenging to muscle in on a space as very competitive as immunology, however Celldex Rehabs ...